Skip to main content
Top
Published in: Cancer Causes & Control 5/2009

01-07-2009 | Original Paper

International patterns and trends in thyroid cancer incidence, 1973–2002

Authors: Briseis A. Kilfoy, Tongzhang Zheng, Theodore R. Holford, Xuesong Han, Mary H. Ward, Andreas Sjodin, Yaqun Zhang, Yana Bai, Cairong Zhu, Grace L. Guo, Nathaniel Rothman, Yawei Zhang

Published in: Cancer Causes & Control | Issue 5/2009

Login to get access

Abstract

During the past several decades, an increasing incidence of thyroid cancer has been reported in many parts of the world. To date, no study has compared the trends in thyroid cancer incidence across continents. We examined incidence data from cancer incidence in five continents (CI5) over the 30-year period 1973–2002 from 19 populations in the Americas, Asia, Europe, and Oceania. Thyroid cancer rates have increased from 1973–1977 to 1998–2002 for most of the populations except Sweden, in which the incidence rates decreased about 18% for both males and females. The average increase was 48.0% among males and 66.7% among females. More recently, the age-adjusted international thyroid cancer incidence rates from 1998 to 2002 varied 5-fold for males and nearly 10-fold for females by geographic region. Considerable variation in thyroid cancer incidence was present for every continent but Africa, in which the incidence rates were generally low. Our analysis of published CI5 data suggests that thyroid cancer rates increased between 1973 and 2002 in most populations worldwide, and that the increase does not appear to be restricted to a particular region of the world or by the underlying rates of thyroid cancer.
Literature
1.
go back to reference Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P (eds) (2007) Cancer incidence in five continents, vol IX. IARC Scientific Publications, Lyon, IARC, p 160 Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P (eds) (2007) Cancer incidence in five continents, vol IX. IARC Scientific Publications, Lyon, IARC, p 160
4.
go back to reference Dos Santos Silva I, Swerdlow AJ (1993) Thyroid cancer epidemiology in England and Wales: time trends and geographical distribution. Br J Cancer 67:330–340PubMed Dos Santos Silva I, Swerdlow AJ (1993) Thyroid cancer epidemiology in England and Wales: time trends and geographical distribution. Br J Cancer 67:330–340PubMed
6.
go back to reference Pettersson B, Adami HO, Wilander E, Coleman MP (1991) Trends in thyroid cancer incidence in Sweden, 1958–1981, by histopathologic type. Int J Cancer 48:28–33PubMedCrossRef Pettersson B, Adami HO, Wilander E, Coleman MP (1991) Trends in thyroid cancer incidence in Sweden, 1958–1981, by histopathologic type. Int J Cancer 48:28–33PubMedCrossRef
7.
go back to reference Qian B, He M, Dong S, Wang J, Chen K (2005) Incidence and mortality of thyroid cancers in Tianjin from 1981 to 2001. Chin J Endocrinol Metab 21:432–434 Qian B, He M, Dong S, Wang J, Chen K (2005) Incidence and mortality of thyroid cancers in Tianjin from 1981 to 2001. Chin J Endocrinol Metab 21:432–434
9.
go back to reference Surveillance, Epidemiology, and End Results (SEER) Program (November 2007 submission). Public-use database (1973–2005). National Cancer Institute DCCPS, Suveillance Research Program, Cancer Statistics Branch, Released April 2008, based on the November 2007 submission Surveillance, Epidemiology, and End Results (SEER) Program (November 2007 submission). Public-use database (1973–2005). National Cancer Institute DCCPS, Suveillance Research Program, Cancer Statistics Branch, Released April 2008, based on the November 2007 submission
10.
go back to reference World Health Organization (1998) In: Hedinger CWE, Sobin LH (eds) Histological typing of thyroid tumours, 2nd edn. Springer, Berlin World Health Organization (1998) In: Hedinger CWE, Sobin LH (eds) Histological typing of thyroid tumours, 2nd edn. Springer, Berlin
11.
go back to reference LiVolsi VA, Asa SL (1994) The demise of follicular carcinoma of the thyroid gland. Thyroid 4:233–236PubMedCrossRef LiVolsi VA, Asa SL (1994) The demise of follicular carcinoma of the thyroid gland. Thyroid 4:233–236PubMedCrossRef
14.
go back to reference Huszno B, Szybinski Z, Przybylik-Mazurek E, Stachura J, Trofimiuk M, Buziak-Bereza M, Gollowski F, Pantoflinski J (2003) Incidence of thyroid cancer in the selected areas of iodine deficiency in Poland. J Endocrinol Invest 26:57–62PubMed Huszno B, Szybinski Z, Przybylik-Mazurek E, Stachura J, Trofimiuk M, Buziak-Bereza M, Gollowski F, Pantoflinski J (2003) Incidence of thyroid cancer in the selected areas of iodine deficiency in Poland. J Endocrinol Invest 26:57–62PubMed
15.
go back to reference World Health Organization (2004). In: de Benoist B, Andersson M, Egli I, Takkouche B, Allen H (eds). Iodine status worldwide: WHO global database on iodine deficiency. Department of Nutrition for Health and Development. World Health Organization, Geneva World Health Organization (2004). In: de Benoist B, Andersson M, Egli I, Takkouche B, Allen H (eds). Iodine status worldwide: WHO global database on iodine deficiency. Department of Nutrition for Health and Development. World Health Organization, Geneva
16.
go back to reference Ferlay J, Bray F, Pisani P, Parkin DM (2004) GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5. Version 2.0. IARC Press, Lyon Ferlay J, Bray F, Pisani P, Parkin DM (2004) GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5. Version 2.0. IARC Press, Lyon
18.
go back to reference Schecter A, Päpke O, Tung KC, Joseph J, Harris TR, Dahlgren J (2005) Polybrominated diphenyl ether flame retardants in the U.S. population: current levels, temporal trends, and comparison with dioxins, dibenzofurans, and polychlorinated biphenyls. J Occup Environ Med 47(3):199–211. doi:10.1097/01.jom.0000158704.27536.d2 MarPubMedCrossRef Schecter A, Päpke O, Tung KC, Joseph J, Harris TR, Dahlgren J (2005) Polybrominated diphenyl ether flame retardants in the U.S. population: current levels, temporal trends, and comparison with dioxins, dibenzofurans, and polychlorinated biphenyls. J Occup Environ Med 47(3):199–211. doi:10.​1097/​01.​jom.​0000158704.​27536.​d2 MarPubMedCrossRef
19.
go back to reference Guvenius DM, Aronsson A, Ekman-Ordeberg G, Bergman A, Noren K (2003) Human prenatal and postnatal exposure to polybrominated diphenyl ethers, polychlorinated biphenyls, polychlorobiphenylols, and pentachlorophenol. Environ Health Perspect 111:1235–1241PubMed Guvenius DM, Aronsson A, Ekman-Ordeberg G, Bergman A, Noren K (2003) Human prenatal and postnatal exposure to polybrominated diphenyl ethers, polychlorinated biphenyls, polychlorobiphenylols, and pentachlorophenol. Environ Health Perspect 111:1235–1241PubMed
22.
go back to reference Memon A, Darif M, Al-Saleh K, Suresh A (2002) Epidemiology of reproductive and hormonal factors in thyroid cancer: evidence from a case–control study in the Middle East. Int J Cancer 97:82–89. doi:10.1002/ijc.1573 PubMedCrossRef Memon A, Darif M, Al-Saleh K, Suresh A (2002) Epidemiology of reproductive and hormonal factors in thyroid cancer: evidence from a case–control study in the Middle East. Int J Cancer 97:82–89. doi:10.​1002/​ijc.​1573 PubMedCrossRef
25.
go back to reference Goodman MT, Kolonel LN, Wilkens LR (1992) The association of body size, reproductive factors and thyroid cancer. Br J Cancer 66:1180–1184PubMed Goodman MT, Kolonel LN, Wilkens LR (1992) The association of body size, reproductive factors and thyroid cancer. Br J Cancer 66:1180–1184PubMed
Metadata
Title
International patterns and trends in thyroid cancer incidence, 1973–2002
Authors
Briseis A. Kilfoy
Tongzhang Zheng
Theodore R. Holford
Xuesong Han
Mary H. Ward
Andreas Sjodin
Yaqun Zhang
Yana Bai
Cairong Zhu
Grace L. Guo
Nathaniel Rothman
Yawei Zhang
Publication date
01-07-2009
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 5/2009
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-008-9260-4

Other articles of this Issue 5/2009

Cancer Causes & Control 5/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine